Vishesh Khanna

3PUBLICATIONS
30CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

Sort by Publication Date:
|Nov 04, 2025
Complete response in metastatic renal cell carcinoma: impact of a persistent primary lesion.

Vishesh Khanna, Ali Raza Khaki

|Feb 03, 2025
MDM2 inhibition is associated with the emergence of TP53-altered clonal hematopoiesis.

Vishesh Khanna, Gohar Eslami, Rochelle Reyes

|Aug 23, 2024
ORIC-101, a Glucocorticoid Receptor Antagonist, in Combination with Nab-Paclitaxel in Patients with Advanced Solid Tumors.

Christopher T Chen, Vishesh Khanna, Shivaani Kummar

Pageof 1

Frequent Collaborators

1 joint publications

Christopher T Chen

1 joint publications

Shivaani Kummar

1 joint publications

Raghad M Abdul-Karim

1 joint publications

David Sommerhalder

1 joint publications

Anthony W Tolcher

1 joint publications

Naoto T Ueno

1 joint publications

Sarah Lindsey Davis

1 joint publications

Douglas W Orr

1 joint publications

Erika Hamilton

1 joint publications

Manish R Patel

Frequent Collaborators

1 joint publications

Christopher T Chen

1 joint publications

Shivaani Kummar

1 joint publications

Raghad M Abdul-Karim

1 joint publications

David Sommerhalder

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us

Top Related Videos

A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies
06:38

A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies

Published on : Apr 12, 2017

14.1K
Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
06:39

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome

Published on : Oct 03, 2018

9.7K
High-Throughput <em>In Vitro</em> Assay using Patient-Derived Tumor Organoids
06:25

High-Throughput <em>In Vitro</em> Assay using Patient-Derived Tumor Organoids

Published on : Jun 14, 2021

5.3K
See more related videos

Top Related Videos

A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies
06:38

A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies

Published on : Apr 12, 2017

14.1K
Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
06:39

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome

Published on : Oct 03, 2018

9.7K
High-Throughput <em>In Vitro</em> Assay using Patient-Derived Tumor Organoids
06:25

High-Throughput <em>In Vitro</em> Assay using Patient-Derived Tumor Organoids

Published on : Jun 14, 2021

5.3K
See more related videos